These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36789593)

  • 41. The Effect of Coronary Lesion Complexity and Preprocedural Revascularization on 5-Year Outcomes After TAVR.
    Minten L; Wissels P; McCutcheon K; Bennett J; Adriaenssens T; Desmet W; Sinnaeve P; Verbrugghe P; Jacobs S; Guler I; Dubois C
    JACC Cardiovasc Interv; 2022 Aug; 15(16):1611-1620. PubMed ID: 35981834
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Long-term outcomes and risk factors of ostial/shaft lesions in unprotected left main coronary artery after percutaneous coronary intervention].
    Yu XP; Zeng Y; Li Y; Wu CY; He JQ; Luo YW
    Zhonghua Yi Xue Za Zhi; 2021 Mar; 101(11):782-785. PubMed ID: 33765718
    [No Abstract]   [Full Text] [Related]  

  • 43. High fibrinogen-to-albumin ratio with type 2 diabetes mellitus is associated with poor prognosis in patients undergoing percutaneous coronary intervention: 5-year findings from a large cohort.
    Wang P; Yuan D; Zhang C; Zhu P; Jia S; Song Y; Tang X; Xu J; Li T; Zeng G; Zhao X; Yang Y; Xu B; Gao R; Yuan J
    Cardiovasc Diabetol; 2022 Mar; 21(1):46. PubMed ID: 35313877
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Coronary atherosclerotic burden assessed by SYNTAX scores and outcomes in surgical, percutaneous or medical strategies: a retrospective cohort study.
    Scudeler TL; Farkouh ME; Hueb W; Rezende PC; Campolina AG; Martins EB; Godoy LC; Soares PR; Ramires JAF; Kalil Filho R
    BMJ Open; 2022 Sep; 12(9):e062378. PubMed ID: 36137633
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Outcomes After Coronary Stenting or Bypass Surgery for Men and Women With Unprotected Left Main Disease: The EXCEL Trial.
    Serruys PW; Cavalcante R; Collet C; Kappetein AP; Sabik JF; Banning AP; Taggart DP; Sabaté M; Pomar J; Boonstra PW; Lembo NJ; Onuma Y; Simonton CA; Morice MC; McAndrew T; Dressler O; Stone GW
    JACC Cardiovasc Interv; 2018 Jul; 11(13):1234-1243. PubMed ID: 29976359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Long-term results of myocardial revascularization in patients with multivessel disease.
    Madiyeva MI; Aripov MA; Pya YV; Goncharov AY; Shakirova GN
    Bratisl Lek Listy; 2023; 124(3):212-220. PubMed ID: 36598313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of SYNTAX score II efficacy with SYNTAX score and TIMI risk score for predicting in-hospital and long-term mortality in patients with ST segment elevation myocardial infarction.
    Karabağ Y; Çağdaş M; Rencuzogullari I; Karakoyun S; Artaç İ; İliş D; Yesin M; Öterkus M; Gokdeniz T; Burak C; Tanboğa IH
    Int J Cardiovasc Imaging; 2018 Aug; 34(8):1165-1175. PubMed ID: 29541904
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The atherogenic index of plasma plays an important role in predicting the prognosis of type 2 diabetic subjects undergoing percutaneous coronary intervention: results from an observational cohort study in China.
    Qin Z; Zhou K; Li Y; Cheng W; Wang Z; Wang J; Gao F; Yang L; Xu Y; Wu Y; He H; Zhou Y
    Cardiovasc Diabetol; 2020 Feb; 19(1):23. PubMed ID: 32085772
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prognostic value of the SYNTAX score in patients with acute coronary syndromes undergoing percutaneous coronary intervention: analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage StrategY) trial.
    Palmerini T; Genereux P; Caixeta A; Cristea E; Lansky A; Mehran R; Dangas G; Lazar D; Sanchez R; Fahy M; Xu K; Stone GW
    J Am Coll Cardiol; 2011 Jun; 57(24):2389-97. PubMed ID: 21658558
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Impact of platelet distribution width on the extent and long-term outcome of patients with stable coronary artery disease post percutaneous coronary intervention].
    Jiang P; Song Y; Xu JJ; Ma YL; Tang XF; Yao Y; Jiang L; Wang HH; Zhang X; Diao XL; Yang YJ; Gao RL; Qiao SB; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Oct; 45(10):862-866. PubMed ID: 29081176
    [No Abstract]   [Full Text] [Related]  

  • 51. Effectiveness of Clinical, Surgical and Percutaneous Treatment to Prevent Cardiovascular Events in Patients Referred for Elective Coronary Angiography: An Observational Study.
    Almeida AS; Fuchs SC; Fuchs FC; Silva AG; Lucca MB; Scopel S; Fuchs FD
    Vasc Health Risk Manag; 2020; 16():285-297. PubMed ID: 32764949
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Percutaneous intervention versus coronary artery bypass graft surgery in left main coronary artery stenosis: a systematic review and meta-analysis.
    Zhang XL; Zhu QQ; Yang JJ; Chen YH; Li Y; Zhu SH; Xie J; Wang L; Kang LN; Xu B
    BMC Med; 2017 Apr; 15(1):84. PubMed ID: 28427392
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Impact of unprotected left main percutaneous coronary intervention on long-term clinical outcomes: a large single-center study.
    Xu L; Gao Z; Song Y; Wang H; Xu J; Jiang P; Jiang L; Tang X; Chen J; Gao L; Song L; Zhang Y; Zhao X; Qiao S; Yang Y; Gao R; Xu B; Yuan J
    Coron Artery Dis; 2019 Jun; 30(4):249-254. PubMed ID: 30762624
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The impact of residual coronary lesions on clinical outcomes after percutaneous coronary intervention: Residual SYNTAX score after percutaneous coronary intervention in patients from the Efficacy of Xience/Promus versus Cypher in rEducing Late Loss after stENTing (EXCELLENT) registry.
    Park KW; Kang J; Kang SH; Ahn HS; Kang HJ; Koo BK; Chae IH; Youn TJ; Oh BH; Park YB; Kandzari D; Kim HS
    Am Heart J; 2014 Mar; 167(3):384-392.e5. PubMed ID: 24576524
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Percutaneous Coronary Intervention Versus Coronary Artery Bypass Graftinge Among Patients with Unprotected Left Main Coronary Artery Disease in the New-Generation Drug-Eluting Stents Era (From the CREDO-Kyoto PCI/CABG Registry Cohort-3).
    Yamamoto K; Shiomi H; Morimoto T; Kadota K; Tada T; Takeji Y; Matsumura-Nakano Y; Yoshikawa Y; Imada K; Domei T; Kaneda K; Taniguchi R; Ehara N; Nawada R; Natsuaki M; Yamaji K; Toyofuku M; Kanemitsu N; Shinoda E; Suwa S; Iwakura A; Tamura T; Soga Y; Inada T; Matsuda M; Koyama T; Aoyama T; Sato Y; Furukawa Y; Ando K; Yamazaki F; Komiya T; Minatoya K; Nakagawa Y; Kimura T;
    Am J Cardiol; 2021 Apr; 145():47-57. PubMed ID: 33454345
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Vázquez DJL; López GA; Guzmán MQ; Cancelo AV; Leal FR; Rios XF; Esteban PP; Fernandez JS; Santos RC; Rodriguez JMV
    Catheter Cardiovasc Interv; 2023 Sep; 102(3):513-520. PubMed ID: 37471716
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prediction of long-term patient outcome after contemporary left main stenting using the SYNTAX and SYNTAX II scores: A comparative analysis from the FAIL-II multicenter registry (failure in left main study with 2nd generation stents-Cardiogroup III study).
    Cerrato E; Barbero U; Quadri G; Ryan N; D'Ascenzo F; Tomassini F; Quirós A; Bellucca S; Conrotto F; Ugo F; Kawamoto H; Rolfo C; Pavani M; Mejia-Renteria H; Gili S; Iannaccone M; Debenedictis M; Baldassarre D; Biondi-Zoccai G; Colombo A; Varbella F; Escaned J
    Catheter Cardiovasc Interv; 2020 Jul; 96(1):E17-E26. PubMed ID: 31478334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic impact of lipoprotein (a) on long-term clinical outcomes in diabetic patients on statin treatment after percutaneous coronary intervention.
    Takahashi N; Dohi T; Funamizu T; Endo H; Wada H; Doi S; Kato Y; Ogita M; Okai I; Iwata H; Okazaki S; Isoda K; Miyauchi K; Shimada K
    J Cardiol; 2020 Jul; 76(1):25-29. PubMed ID: 32089480
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The incremental impact of residual SYNTAX score on long-term clinical outcomes in patients with multivessel coronary artery disease treated by percutaneous coronary interventions.
    Witberg G; Lavi I; Assali A; Vaknin-Assa H; Lev E; Kornowski R
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):3-10. PubMed ID: 25413668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Impact of direct bilirubin on the long-term outcome of patients with acute coronary syndrome post percutaneous coronary intervention].
    Xu LJ; Song Y; Xu JJ; Gao Z; Tang XF; Wang HH; Liu R; Jiang P; Jiang L; Yao Y; Gao LJ; Zhang Y; Song L; Zhao XY; Chen J; Gao RL; Qiao SB; Yang YJ; Xu B; Yuan JQ
    Zhonghua Xin Xue Guan Bing Za Zhi; 2018 May; 46(5):352-358. PubMed ID: 29804436
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.